Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Cytokine1 who wrote (747)	10/19/1998 3:12:00 AM
From: Rocketman	Respond to of 3202

Thanks Cyto, haven't checked out their site in a while. I noticed several press releases there that never made it out on PR Newswire. I guess these are just being ignored by the mainstream press, even though they seem pretty significant to me. For instance: Incyte Releases New Rat GEM Microarray to Help Researchers Profile New Drugs and Determine Disease Pathways Palo Alto, CA - August 4, 1998 - ----------------------- Incyte and Synomics to Collaborate on New Software Development Initiative in Genomics Palo Alto, CA, and Cambridge, UK – September 15, 1998 – ------------------------------ Incyte Releases New, Enhanced Integrated Bioinformatics Software Promoting Enterprise-wide Genomics Research Palo Alto, CA– October 7, 1998 ----------------- Incyte Releases First Sequence-Verified Gene Expression Microarray of Public Domain Data New tool helps researchers uncover important genetic information from the wealth of public-domain data. Palo Alto, California — October 7, 1998 -------------------- See: incyte.com Rman

To: Cytokine1 who wrote (747)	10/19/1998 11:17:00 AM
From: Rocketman	Read Replies (1) \| Respond to of 3202

Got this one out of todays BioCentury dated 8/19/98. I find no record of it being announced anywhere else at INCY or Amgen, can't find any Synteni reference to this deal either. It isn't mentioned in the 1/26/98 BioCentury either, just that INCY acquired Synteni. Still need to see if it is mentioned in any INCY SEC filings: <<<<<<<<<<< Amgen Inc. (AMGN), Thousand Oaks, Calif. Incyte Pharmaceuticals Inc. (INCY), Palo Alto, Calif. Business: Enabling technology The companies expanded a January agreement on microarray technology between AMGN and Synteni Inc. (Fremont, Calif.) prior to INCY's acquisition of Synteni (see BioCentury, Jan. 26). As ex-panded, AMGN will receive broader access to the microarray technology. >>>>>>>>>>> What other secrets are out there? Rman